The Blunt Truth

AUGUST 13, 2019

CBD is “thriving” in the current regulatory environment, but is it doing so illegally? The FDA is collecting data to fill these gaps. The Working Group is continuing to collect and review information relevant to the science of CBD, as well as investigating possible pathways for regulating CBD. As former U.S.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

FEBRUARY 2, 2022

– Flora seeks approval to take their patent-pending, cannabinoid-based product through clinical trials under an EUA from INVIMA (Colombian FDA). Dr. Manalo-Morgan has spent the last 5 years researching cannabis and has specialized in the formulation of cannabinoid products for clinical trials.

Cannabinoids 40

Cannabinoids Clinical Trials Events Cultivation 40

Cannabis Law Report

DECEMBER 7, 2021

Radicle Science re-imagined clinical trials resulting in 10x cheaper, faster, and larger studies that can finally prove or predict which nonprescription health products to use for a desired effect, benefiting consumers, healthcare providers and brands.”. in less than four days.

Clinical Trials 40

Clinical Trials CBD Data Sleep 40

Cannabis Law Report

SEPTEMBER 21, 2021

He also serves as the president of the Oregon Business Collective, a coalition of cannabis entities. If we are going to provide medicinal cannabis opportunities covered by insurance, we need the ability to go through clinical trials and testing. Hunter, thanks for talking with us. What can Oregon do to protect itself?

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

Cannabis Law Report

JANUARY 6, 2022

“I have watched how Flora, in a short time, has emerged as a leader in building a diversified global cannabis company, from its low-cost manufacturing to the clinical studies from its Flora Pharma division to its premium brand portfolio. About Flora Growth Corp. Forward-looking statements are only predictions.

Research and Development 52

Research and Development Events Clinical Trials Business 52

Cannabis Law Report

SEPTEMBER 3, 2019

Industrial-scale production will be supported by leading infrastructure designed with ISO standard-built cleanrooms and critical environments that accommodate global Good Manufacturing Practices (“GMP”) workflow. Website: www.medipharmlabs.com.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

DECEMBER 21, 2021

This service is available to businesses, K-12 schools, universities, event venues, medical offices, hospitality groups, and more to facilitate the safe return of people to in-person environments. Tests include on-site rapid antigen (results in under 20 minutes) and on-site RT-PCR sample collection (results in 24 hours).

Research and Development 40

Research and Development Supply Chain Data Business 40

Cannabis Law Report

AUGUST 30, 2021

‘Psychedelic renaissance’ sees first legal collection of Australia’s medicinal magic mushrooms. Key points: This will be Australia’s first legal collection of magic mushrooms. The ABC reports. They will be studied for their psychoactive properties. Psychedelic renaissance.

Clinical Trials 105

Clinical Trials Collective Therapy Treatment 105

The Cannigma

DECEMBER 12, 2022

They do carry the risk of a “bad trip,” in which anxiety, confusion and unpredictable behavior can be potentially dangerous in the wrong environment. Making sure you have the proper set (the state of your mind) and setting (your environment) is important to minimize these risks.

History 141

History Microdosing Research and Development Clinical Trials 141

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JUNE 2, 2021

Samples will be collected via anterior nasal swabs that offer ease-of-use for all ages. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S. Food and Drug Administration (U.S.

Clinical Trials 63

Clinical Trials Therapy Research and Development Collective 63